Revolution Medicines
Price & Volume
Stats
See moreOpen | $36.53 |
Previous Close | $36.02 |
Day Range | $36.35-$36.84 |
52W Range | $29.17-$62.40 |
Market Cap | $6.7B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $742,000 |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$604.7M |
Diluted EPS | -$4.52 |
News
See moreYahoo Finance • yesterday
Revolution Medicines’ SWOT analysis: stock poised for growth amid clinical progress
Yahoo Finance • 9 days ago
Revolution Medicines outlines $1.03B–$1.09B net loss guidance for 2025 amid expanded global RAS portfolio strategy
Yahoo Finance • 9 days ago
Revolution Medicines Inc (NASDAQ:RVMD) Reports Q2 2025 Earnings Miss, Shares Drop 4.5% After-Hours
Yahoo Finance • 9 days ago
Revolution Medicines GAAP EPS of -$1.31 misses by $0.29
About
CEO | Dr. Mark A. Goldsmith M.D., Ph.D. |
Address | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 700 |
